sfedson's Top Recommendations

These recommendations were last updated about an hour ago.

	Early Ultrafiltration in Patients With Decompensated Heart Failure and Diuretic Resistance [My Copy] J Am Coll Cardiol, Vol. 46, No. 11. (6 December 2005), pp. 2047-2051. by Maria R. Costanzo, Mitchell Saltzberg, Jeanne O'Sullivan, Paul Sobotka posted by 1 person brainsman2000
	Ultrafiltration Versus Usual Care for Hospitalized Patients With Heart Failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) Trial [My Copy] J Am Coll Cardiol, Vol. 46, No. 11. (6 December 2005), pp. 2043-2046. by Bradley A. Bart, Andrew Boyle, Alan J. Bank, et al.Inder Anand, Maria T. Olivari, Mark Kraemer, Shari Mackedanz, Paul A. Sobotka, Mike Schollmeyer, Steven R. Goldsmith posted by 1 person brainsman2000
	Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure [My Copy] Circulation, Vol. 113, No. 5. (7 February 2006), pp. 671-678. by Hans L. Hillege, Dorothea Nitsch, Marc A. Pfeffer, et al.Karl Swedberg, John J. V. Mcmurray, Salim Yusuf, Christopher B. Granger, Eric L. Michelson, Jan Ostergren, Jan H. Cornel, Dick de Zeeuw, Stuart Pocock, Dirk J. van Veldhuisen, on behalf of the Candesartan in Heart Failure posted by 1 person brainsman2000
	Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 40, No. 5. (November 2002), pp. 974-982. by Yoshio Iwashima, Takeshi Horio, Yoichi Takami, et al.Takashi Inenaga, Toshio Nishikimi, Shuichi Takishita, Yuhei Kawano posted by 1 person philipeto
	A Conceptual Model of Quality of Life in Relation to Heart Failure [My Copy] Journal of Cardiac Failure, Vol. 11, No. 3. (April 2005), pp. 173-176. by T. Rector posted by 1 person philipeto
	Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration [My Copy] QJM, Vol. 89, No. 9. (1 September 1996), pp. 681-684. by V. Tormey, P. J. Conlon, J. Farrell, J. Horgan, J. J. Walshe
	Peritoneal dialysis in patients with congestive heart failure. [My Copy] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 21 Suppl 2 (July 2006) by Nynke Cnossen, Jeroen P. Kooman, Constantijn J. Konings, Jan-Melle M. van Dantzig, Frank M. van der Sande, Karel Leunissen
	Mortality studies comparing peritoneal dialysis and hemodialysis: what do they tell us? [My Copy] Kidney international. Supplement, No. 103. (November 2006) by E. F. Vonesh, J. J. Snyder, R. N. Foley, A. J. Collins
	What is the place of peritoneal dialysis in the integrated treatment of renal failure? [My Copy] Kidney international, Vol. 54, No. 6. (December 1998), pp. 2234-2240. by G. A. Coles, J. D. Williams
	Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. [My Copy] Kidney international, Vol. 64, No. 3. (September 2003), pp. 1071-1079. by Austin G. Stack, Donald A. Molony, Noor S. Rahman, Akinsansoye Dosekun, Bhamidipati Murthy
	Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation [My Copy] Nephrol. Dial. Transplant., Vol. 20, No. suppl_7. (1 July 2005), pp. vii32-36. by Lazaro Gotloib, Roberto Fudin, Michaela Yakubovich, Joerg Vienken
	Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) [My Copy] Eur Heart J, Vol. 27, No. 10. (2 May 2006), pp. 1216-1222. by Martin R. Cowie, Michel Komajda, Tarita Murray-Thomas, Jonathan Underwood, Barry Ticho, on behalf of the POSH Investigators
	Anemia: the point of convergence or divergence for kidney disease and heart failure? [My Copy] Journal of the American College of Cardiology, Vol. 53, No. 8. (24 February 2009), pp. 639-647. by Amir Kazory, Edward A. Ross posted by 1 person guhjy
	Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance [My Copy] Eur J Heart Fail, Vol. 10, No. 2. (1 February 2008), pp. 188-195. by Marco Metra, Savina Nodari, Giovanni Parrinello, et al.Tania Bordonali, Silvia Bugatti, Rossella Danesi, Benedetta Fontanella, Carlo Lombardi, Patrizia Milani, Giulia Verzura, Gadi Cotter, Howard Dittrich, Barry M. Massie, Livio D. Cas
	The Challenge of Correcting Volume Overload in Hospitalized Patients With Decompensated Heart Failure [My Copy] J Am Coll Cardiol, Vol. 49, No. 6. (13 February 2007), pp. 684-686. by Uri Elkayam, Parta Hatamizadeh, Munir Janmohamed
	The UNLOAD Trial: A "Nephrologic" Standpoint [My Copy] J Am Coll Cardiol, Vol. 50, No. 8. (21 August 2007), 820. by Amir Kazory, Ahsan A. Ejaz, Edward A. Ross
	Relationship of Venous Congestion to Worsening Renal Function [My Copy] J Am Coll Cardiol, Vol. 54, No. 7. (11 August 2009), pp. 661-a-662. by Farhan Maqsood, Harold M. Szerlip
	Hemofiltration as short-term treatment for refractory congestive heart failure. [My Copy] The American journal of medicine, Vol. 83, No. 1. (July 1987), pp. 43-48. by A. Rimondini, C. M. Cipolla, P. Della Bella, et al.S. Grazi, E. Sisillo, G. Susini, M. D. Guazzi
	Clinical benefit and approach of ultrafiltration in acute heart failure. [My Copy] Cardiology, Vol. 96, No. 3-4. (2001), pp. 144-154. by A. Sharma, D. D. Hermann, R. L. Mehta
	Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD) [My Copy] J Am Coll Cardiol, Vol. 42, No. 4. (20 August 2003), pp. 705-708. by Michael Domanski, James Norman, Bertram Pitt, Mark Haigney, Stephen Hanlon, Eliot Peyster
	Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor? [My Copy] J Am Coll Cardiol, Vol. 47, No. 1. (3 January 2006), pp. 1-8. by Robert W. Schrier
	Drawbacks and Prognostic Value of Formulas Estimating Renal Function in Patients With Chronic Heart Failure and Systolic Dysfunction [My Copy] Circulation, Vol. 114, No. 15. (10 October 2006), pp. 1572-1580. by Tom D. J. Smilde, Dirk J. van Veldhuisen, Gerjan Navis, Adriaan A. Voors, Hans L. Hillege
	Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines [My Copy] Nephrol. Dial. Transplant., Vol. 22, No. 7. (1 July 2007), pp. 2013-2019. by Carmelo Libetta, Vincenzo Sepe, Manuela Zucchi, et al.Patrizia Pisacco, Laura Cosmai, Federica Meloni, Carlo Campana, Teresa Rampino, Cristina Monti, Luigi Tavazzi, Antonio Dal Canton
	Contemporary Trends in the Pharmacological and Extracorporeal Management of Heart Failure: A Nephrologic Perspective [My Copy] Circulation, Vol. 117, No. 7. (19 February 2008), pp. 975-983. by Amir Kazory, Edward A. Ross
	Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. [My Copy] American heart journal, Vol. 138, No. 2 Pt 1. (August 1999), pp. 285-290. by M. S. Weinfeld, G. M. Chertow, L. W. Stevenson
	Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure [My Copy] J Am Coll Cardiol, Vol. 43, No. 1. (7 January 2004), pp. 61-67. by Daniel E. Forman, Javed Butler, Yongfei Wang, et al.William T. Abraham, Christopher M. O'Connor, Stephen S. Gottlieb, Evan Loh, Barry M. Massie, Michael W. Rich, Lynne W. Stevenson, James B. Young, Harlan M. Krumholz
	Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction [My Copy] Eur J Heart Fail, Vol. 9, No. 9. (1 September 2007), pp. 872-878. by Kevin Damman, Gerjan Navis, Tom D. J. Smilde, et al.Adriaan A. Voors, Wim van der Bij, Dirk J. van Veldhuisen, Hans L. Hillege
	The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease [My Copy] J Am Coll Cardiol, Vol. 44, No. 8. (19 October 2004), pp. 1587-1592. by Justin Ezekowitz, Finlay A. Mcalister, Karin H. Humphries, et al.Colleen M. Norris, Marcello Tonelli, William A. Ghali, Merril L. Knudtson, Approach Investigators
	Anemia and Renal Insufficiency Are Independent Risk Factors for Death among Patients with Congestive Heart Failure Admitted to Community Hospitals: A Population-Based Study [My Copy] J Am Soc Nephrol, Vol. 13, No. 7. (1 July 2002), pp. 1928-1936. by William M. Mcclellan, W. Dana Flanders, Robert D. Langston, Claudine Jurkovitz, Rodney Presley
	Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction [My Copy] J Am Coll Cardiol, Vol. 38, No. 4. (1 October 2001), pp. 955-962. by Amin Al-Ahmad, William M. Rand, Guruprasad Manjunath, et al.Marvin A. Konstam, Deeb N. Salem, Andrew S. Levey, Mark J. Sarnak
	Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure [My Copy] Circulation, Vol. 102, No. 2. (11 July 2000), pp. 203-210. by Hans L. Hillege, Armand R. J. Girbes, Pieter J. de Kam, et al.Frans Boomsma, Dick de Zeeuw, Andrew Charlesworth, John R. Hampton, Dirk J. van Veldhuisen
	Renal Impairment and Outcomes in Heart Failure: Systematic Review and Meta-Analysis [My Copy] J Am Coll Cardiol, Vol. 47, No. 10. (16 May 2006), pp. 1987-1996. by Grace L. Smith, Judith H. Lichtman, Michael B. Bracken, et al.Michael G. Shlipak, Christopher O. Phillips, Paul Dicapua, Harlan M. Krumholz
	Ultrafiltration for decompensated heart failure: renal implications. [My Copy] Heart (British Cardiac Society), Vol. 95, No. 13. (1 July 2009), pp. 1047-1051. by A. Kazory, E. A. Ross posted by 1 person guhjy
	Congestive heart failure as an indication for continuous renal replacement therapy [My Copy] Kidney Int, Vol. 56, No. S72. (November 1999), pp. S95-S98. by Matthias Brause, Christine E. Deppe, Markus Hollenbeck, et al.Katrin Ivens, Frank C. Schoebel, Bernd Grabensee, Peter Heering
	Exploratory study of relationship between hospitalized heart failure patients and chronic renal replacement therapy [My Copy] Nephrol. Dial. Transplant., Vol. 24, No. 8. (1 August 2009), pp. 2518-2523. by Kelly V. Liang, Eddie L. Greene, Amy W. Williams, et al.Charles A. Herzog, David O. Hodge, Theophilus E. Owan, Margaret M. Redfield posted by 1 person philipeto
	A critical look at acute decompensated heart failure from a nephrologist's perspective [My Copy] Nephrol. Dial. Transplant., Vol. 24, No. 7. (1 July 2009), pp. 2024-2026. by Christopher T. Chan posted by 1 person philipeto
	Renal replacement therapy for heart failure patients: in whom, when and which therapy to use? [My Copy] Nephrol. Dial. Transplant., Vol. 24, No. 8. (1 August 2009), pp. 2314-2315. by Gerard M. London, Bruno Pannier
	End Points for Clinical Trials in Acute Heart Failure Syndromes [My Copy] J Am Coll Cardiol, Vol. 53, No. 24. (16 June 2009), pp. 2248-2258. by Larry A. Allen, Adrian F. Hernandez, Christopher M. O'Connor, G. Michael Felker
	Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study [My Copy] Nephrol. Dial. Transplant., Vol. 24, No. 1. (1 January 2009), pp. 186-193. by Ruth C. Campbell, Xuemei Sui, Gerasimos Filippatos, et al.Thomas E. Love, Christy Wahle, Paul W. Sanders, Ali Ahmed posted by 1 person guhjy
	Acute decompensated heart failure and the cardiorenal syndrome. [My Copy] Critical care medicine, Vol. 36, No. 1 Suppl. (January 2008), pp. S75-S88. by Kelly V. Liang, Amy W. Williams, Eddie L. Greene, Margaret M. Redfield posted by 1 person guhjy
	Cardiorenal syndrome. [My Copy] Journal of the American College of Cardiology, Vol. 52, No. 19. (4 November 2008), pp. 1527-1539. by Claudio Ronco, Mikko Haapio, Andrew A. House, Nagesh Anavekar, Rinaldo Bellomo posted by 1 person guhjy
	Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure [My Copy] J Am Coll Cardiol, Vol. 49, No. 6. (13 February 2007), pp. 675-683. by Maria R. Costanzo, Maya E. Guglin, Mitchell T. Saltzberg, et al.Mariell L. Jessup, Bradley A. Bart, John R. Teerlink, Brian E. Jaski, James C. Fang, Erika D. Feller, Garrie J. Haas, Allen S. Anderson, Michael P. Schollmeyer, Paul A. Sobotka, For The Unload Trial Investigators posted by 1 person djmonstermo
	Cardiorenal Interactions: Insights From the ESCAPE Trial [My Copy] J Am Coll Cardiol, Vol. 51, No. 13. (1 April 2008), pp. 1268-1274. by Anju Nohria, Vic Hasselblad, Amanda Stebbins, et al.Daniel F. Pauly, Gregg C. Fonarow, Monica Shah, Clyde W. Yancy, Robert M. Califf, Lynne W. Stevenson, James A. Hill posted by 1 person guhjy
	Chronic Kidney Disease and Mortality Risk: A Systematic Review [My Copy] J Am Soc Nephrol, Vol. 17, No. 7. (1 July 2006), pp. 2034-2047. by Marcello Tonelli, Natasha Wiebe, Bruce Culleton, et al.Andrew House, Chris Rabbat, Mei Fok, Finlay Mcalister, Amit X. Garg posted by 2 people cquinsac guhjy
	Management of acute decompensated heart failure [My Copy] CMAJ, Vol. 176, No. 6. (13 March 2007), pp. 797-805. by Larry A. Allen, Christopher M. O'Connor posted by 3 people guhjy abhilash_patangay MedTechJC
	The Cardiovascular Effects of Arteriovenous Fistulas in Chronic Kidney Disease: A Cause for Concern? [My Copy] Seminars in Dialysis, Vol. 19, No. 5. (September 2006), pp. 349-352. by Jennifer M. MacRae, Adeera Levin, Israel Belenkie posted by 1 person philipeto
	How to read a paper: Papers that summarise other papers (systematic reviews and meta-analyses) [My Copy] BMJ, Vol. 315, No. 7109. (13 September 1997), pp. 672-675. by Trisha Greenhalgh posted by 11 people philipeto sabrenawells iskanbasal coffeekev Borelli inbetweener soumitri_varadarajan wandall Sciences_communication_societe avidran ajaymalik
	TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program [My Copy] J Immunol, Vol. 183, No. 5. (1 September 2009), pp. 2984-2994. by Sonia Chamorro, Juan J. Garcia-Vallejo, Wendy W. J. Unger, et al.Rosette J. Fernandes, Sven C. M. Bruijns, Sandra Laban, Bart O. Roep, Bert A. 'T Hart, Yvette van Kooyk posted by 1 person dalia
	Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells [My Copy] Clinical Immunology (05 August 2009) by Klára Sochorová, Vít Budinský, Daniela Rožková, et al.Zuzana Tobiasová, Sylvie Dusilová-Sulková, Radek Špíšek, Jiřina Bartůňková posted by 1 person dalia
	IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells [My Copy] J Immunol, Vol. 183, No. 4. (15 August 2009), pp. 2475-2483. by Babak Baban, Phillip R. Chandler, Madhav D. Sharma, et al.Jeanene Pihkala, Pandelakis A. Koni, David H. Munn, Andrew L. Mellor posted by 3 people ashkelon13 dalia leliavski
	Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. [My Copy] Nature medicine, Vol. 6, No. 10. (October 2000), pp. 1176-1182. by L. Kappos, G. Comi, H. Panitch, et al.J. Oger, J. Antel, P. Conlon, L. Steinman posted by 1 person dalia
	Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. [My Copy] Nature medicine, Vol. 2, No. 10. (October 1996), pp. 1109-1115. by A. A. Vandenbark, Y. K. Chou, R. Whitham, et al.M. Mass, A. Buenafe, D. Liefeld, D. Kavanagh, S. Cooper, G. A. Hashim, H. Offner posted by 1 person dalia
	Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies. [My Copy] The Journal of experimental medicine, Vol. 171, No. 6. (1 June 1990), pp. 1943-1955. by D. M. Zaller, G. Osman, O. Kanagawa, L. Hood posted by 1 person dalia
	T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study. [My Copy] Clinical and experimental immunology, Vol. 131, No. 1. (January 2003), pp. 155-168. by A. Van der Aa, N. Hellings, R. Medaer, et al.G. Gelin, Y. Palmers, J. Raus, P. Stinissen posted by 1 person dalia
	Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. [My Copy] Nature, Vol. 292, No. 5818. (2 July 1981), pp. 60-61. by A. Ben-Nun, H. Wekerle, I. R. Cohen posted by 1 person dalia
	Antigen-specific therapies in MS - Current concepts and novel approaches. [My Copy] Journal of the neurological sciences, Vol. 274, No. 1-2. (15 November 2008), pp. 18-22. by A. Lutterotti, M. Sospedra, R. Martin posted by 1 person dalia
	Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. [My Copy] Archives of neurology, Vol. 64, No. 10. (October 2007), pp. 1407-1415. by A. Bar-Or, T. Vollmer, J. Antel, et al.D. L. Arnold, C. A. Bodner, D. Campagnolo, J. Gianettoni, F. Jalili, N. Kachuck, Y. Lapierre, M. Niino, J. Oger, M. Price, S. Rhodes, W. H. Robinson, F. D. Shi, P. J. Utz, F. Valone, L. Weiner, L. Steinman, H. Garren posted by 1 person dalia
	Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100 beta. [My Copy] Journal of neural transmission. Supplementum, Vol. 49 (1997), pp. 43-51. by K. Kojima, H. Wekerle, H. Lassmann, T. Berger, C. Linington posted by 1 person dalia
	The T Lymphocyte in Experimental Allergic Encephalomyelitis [My Copy] Annual Review of Immunology, Vol. 8, No. 1. (1990), pp. 579-621. by S. S. Zamvil, L. Steinman posted by 1 person dalia
	Immunological Aspects of Demyelinating Diseases [My Copy] Annual Review of Immunology, Vol. 10, No. 1. (1992), pp. 153-187. by Roland Martin, Henry F. Mcfarland, Dale E. Mcfarlin posted by 1 person dalia
	Dendritic cells for active immunotherapy: optimizing design and manufacture in order to develop commercially and clinically viable products. [My Copy] Vaccine, Vol. 25 Suppl 2 (27 September 2007) by C. A. Nicolette, D. Healey, I. Tcherepanova, et al.P. Whelton, T. Monesmith, L. Coombs, L. H. Finke, T. Whiteside, F. Miesowicz posted by 1 person dalia
	Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. [My Copy] Journal of immunological methods, Vol. 268, No. 2. (15 October 2002), pp. 131-140. by T. G. Berger, B. Feuerstein, E. Strasser, et al.U. Hirsch, D. Schreiner, G. Schuler, B. Schuler-Thurner posted by 1 person dalia
	Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. [My Copy] Journal of immunological methods, Vol. 223, No. 1. (1 February 1999), pp. 1-15. by B. Thurner, C. Röder, D. Dieckmann, et al.M. Heuer, M. Kruse, A. Glaser, P. Keikavoussi, E. Kämpgen, A. Bender, G. Schuler posted by 1 person dalia
	Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. [My Copy] The Journal of experimental medicine, Vol. 195, No. 1. (7 January 2002), pp. 15-21. by M. Menges, S. Rössner, C. Voigtländer, et al.H. Schindler, N. A. Kukutsch, C. Bogdan, K. Erb, G. Schuler, M. B. Lutz posted by 1 person dalia
	Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? [My Copy] Trends in immunology, Vol. 23, No. 9. (September 2002), pp. 445-449. by M. B. Lutz, G. Schuler posted by 1 person dalia
	Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 47. (25 November 2008), pp. 18442-18447. by P. Terness, T. Oelert, S. Ehser, et al.J. J. Chuang, I. Lahdou, C. Kleist, F. Velten, G. J. Hämmerling, B. Arnold, G. Opelz posted by 1 person dalia
	Dendritic CellsSpecialized and Regulated Antigen Processing Machines [My Copy] Cell, Vol. 106, No. 3. (10 August 2001), pp. 255-258. by Ira Mellman, Ralph M. Steinman posted by 1 person dalia
	Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides [My Copy] Human Immunology, Vol. 64, No. 2. (February 2003), pp. 245-255. by J. Kessler posted by 1 person dalia
	Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. [My Copy] Journal of neuroimmunology, Vol. 195, No. 1-2. (March 2008), pp. 140-145. by A. Vaknin-Dembinsky, G. Murugaiyan, D. A. Hafler, A. L. Astier, H. L. Weiner posted by 1 person dalia
	Dendritic Cells in Immunity and Tolerance—Do They Display Opposite Functions? [My Copy] Immunity, Vol. 19, No. 1. (July 2003), pp. 5-8. by Muriel Moser posted by 1 person dalia
	Modern multiple sclerosis treatment - what is approved, what is on the horizon. [My Copy] Drug discovery today, Vol. 13, No. 23-24. (December 2008), pp. 1013-1025. by G. Pilz, P. Wipfler, G. Ladurner, J. Kraus posted by 1 person dalia
	Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes. [My Copy] Vox sanguinis, Vol. 84, No. 3. (April 2003), pp. 228-236. by A. Moldenhauer, M. M. Nociari, S. Dias, P. Lalezari, M. A. Moore posted by 1 person dalia
	Monocyte-derived dendritic cells as antigen-presenting cells in T-cell proliferation and cytokine production. [My Copy] Methods in molecular medicine, Vol. 138 (2008), pp. 97-106. by S. S. Sung posted by 1 person dalia
	Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application. [My Copy] Cytotechnology, Vol. 42, No. 3. (September 2003), pp. 121-131. by H. R. Bohnenkamp, T. Noll posted by 1 person dalia
	Prevention of type 1 diabetes by immature dendritic cells treated with an ethanol extract of Paecilomyces hepiali Chen mycelium. [My Copy] Methods and findings in experimental and clinical pharmacology, Vol. 30, No. 6. (g 2008), pp. 421-429. by C. Zhang, X. Zou, G. Leluo, J. Xu, M. Xiang posted by 1 person dalia
	Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. [My Copy] Diabetes, Vol. 57, No. 7. (July 2008), pp. 1759-1767. by R. Abdi, P. Fiorina, C. N. Adra, M. Atkinson, M. H. Sayegh posted by 1 person dalia
	Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection. [My Copy] Clinical and vaccine immunology : CVI, Vol. 16, No. 2. (February 2009), pp. 233-240. by T. L. Whiteside, P. Piazza, A. Reiter, et al.J. Stanson, N. C. Connolly, C. R. Rinaldo, S. A. Riddler posted by 1 person dalia
	Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection. [My Copy] The Journal of infectious diseases, Vol. 191, No. 10. (15 May 2005), pp. 1680-1685. by F. García, M. Lejeune, N. Climent, et al.C. Gil, J. Alcamí, V. Morente, L. Alós, A. Ruiz, J. Setoain, E. Fumero, P. Castro, A. López, A. Cruceta, C. Piera, E. Florence, A. Pereira, A. Libois, N. González, M. Guilá, M. Caballero, F. Lomeña, J. Joseph, J. M. Miró, T. Pumarola, M. Plana, J. M. Gatell, T. Gallart posted by 1 person dalia
	Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report. [My Copy] Cancer biotherapy & radiopharmaceuticals, Vol. 24, No. 3. (June 2009), pp. 311-319. by R. O. Dillman, S. R. Selvan, P. M. Schiltz, et al.E. F. McClay, N. M. Barth, C. DePriest, C. de Leon, C. Mayorga, A. N. Cornforth, K. Allen posted by 1 person dalia
	Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells. [My Copy] Journal of leukocyte biology, Vol. 84, No. 1. (July 2008), pp. 124-133. by A. E. Anderson, B. L. Sayers, M. A. Haniffa, et al.D. J. Swan, J. Diboll, X. N. Wang, J. D. Isaacs, C. M. Hilkens posted by 1 person dalia
	Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. [My Copy] The Journal of experimental medicine, Vol. 179, No. 4. (1 April 1994), pp. 1109-1118. by F. Sallusto, A. Lanzavecchia posted by 1 person dalia
	High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 169, No. 1. (1 July 2002), pp. 548-556. by R. Weissert, J. Kuhle, K. L. de Graaf, et al.W. Wienhold, M. M. Herrmann, C. Müller, T. G. Forsthuber, K. H. Wiesmüller, A. Melms posted by 1 person dalia
	Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. [My Copy] Journal of neuroimmunology, Vol. 46, No. 1-2. (July 1993), pp. 33-42. by C. M. Pelfrey, J. L. Trotter, L. R. Tranquill, H. F. McFarland posted by 1 person dalia
	Human leukocyte antigen studies in multiple sclerosis. [My Copy] Annals of neurology, Vol. 36 Suppl (1994) by J. Hillert posted by 1 person dalia
	Multiple sclerosis in time and space--geographic clues to cause. [My Copy] Journal of neurovirology, Vol. 6 Suppl 2 (May 2000) by J. F. Kurtzke posted by 1 person dalia
	Genetic basis for clinical expression in multiple sclerosis. [My Copy] Brain : a journal of neurology, Vol. 125, No. Pt 1. (January 2002), pp. 150-158. by L. F. Barcellos, J. R. Oksenberg, A. J. Green, et al.P. Bucher, J. B. Rimmler, S. Schmidt, M. E. Garcia, R. R. Lincoln, M. A. Pericak-Vance, J. L. Haines, S. L. Hauser, posted by 1 person dalia
	Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli. [My Copy] Transplantation, Vol. 52, No. 3. (September 1991), pp. 522-526. by M. Furue, Y. Ishibashi posted by 1 person dalia
	The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 144, No. 4. (15 February 1990), pp. 1418-1424. by F. J. Dumont, M. R. Melino, M. J. Staruch, S. L. Koprak, P. A. Fischer, N. H. Sigal posted by 1 person dalia
	Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. [My Copy] The Journal of experimental medicine, Vol. 204, No. 1. (22 January 2007), pp. 191-201. by K. V. Tarbell, L. Petit, X. Zuo, et al.P. Toy, X. Luo, A. Mqadmi, H. Yang, M. Suthanthiran, S. Mojsov, R. M. Steinman posted by 1 person dalia
	Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. [My Copy] Immunity, Vol. 26, No. 4. (April 2007), pp. 519-531. by B. León, M. López-Bravo, C. Ardavín posted by 1 person dalia
	Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 175, No. 3. (1 August 2005), pp. 1373-1381. by M. Rossi, J. W. Young posted by 1 person dalia
	In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. [My Copy] Journal of hematotherapy & stem cell research, Vol. 9, No. 2. (April 2000), pp. 183-194. by H. Cao, V. Vergé, C. Baron, et al.C. Martinache, A. Leon, S. Scholl, N. C. Gorin, J. Salamero, S. Assari, J. Bernard, M. Lopez posted by 1 person dalia
	Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. [My Copy] Cell, Vol. 106, No. 3. (10 August 2001), pp. 259-262. by Y. J. Liu posted by 1 person dalia
	Dendritic cells as a tool to induce anergic and regulatory T cells. [My Copy] Trends in immunology, Vol. 22, No. 7. (July 2001), pp. 394-400. by H. Jonuleit, E. Schmitt, K. Steinbrink, A. H. Enk posted by 1 person dalia
	IL-17 and Th17 Cells. [My Copy] Annual review of immunology, Vol. 27 (2009), pp. 485-517. by T. Korn, E. Bettelli, M. Oukka, V. K. Kuchroo posted by 1 person dalia
	Dendritic cell regulation of TH1-TH2 development. [My Copy] Nature immunology, Vol. 1, No. 3. (September 2000), pp. 199-205. by M. Moser, K. M. Murphy posted by 1 person dalia
	Tolerogenic dendritic cells in health and disease: friend and foe! [My Copy] European journal of dermatology : EJD, Vol. 17, No. 6. (c 2007), pp. 476-491. by H. S. Adler, K. Steinbrink posted by 1 person dalia
	Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). [My Copy] Neurology, Vol. 33, No. 11. (November 1983), pp. 1444-1452. by J. F. Kurtzke posted by 1 person dalia
	Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. [My Copy] Neurology, Vol. 46, No. 4. (April 1996), pp. 907-911. by F. D. Lublin, S. C. Reingold posted by 1 person dalia
	Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis [My Copy] J Immunol, Vol. 172, No. 6. (15 March 2004), pp. 3893-3904. by Bibiana Bielekova, Myong-Hee Sung, Nadja Kadom, Richard Simon, Henry Mcfarland, Roland Martin posted by 1 person dalia